| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $4.64 ▲ +1.59% | Yesterday | $4.54 ▼ -0.67% | Tomorrow's Larimar Therapeutics Inc. Common Stock (LRMR) setup is anchored to $4.57 and targets $4.64 (+1.59%). The near-term read is upside; watch $4.71 / $4.43 because daily realized volatility is about 8.00%. |
Tomorrow's Larimar Therapeutics Inc. Common Stock (LRMR) setup is anchored to $4.57 and targets $4.64 (+1.59%). The near-term read is upside; watch $4.71 / $4.43 because daily realized volatility is about 8.00%. | ||||
| Week | $4.80 ▲ +4.95% | Last Week | $4.47 ▼ -2.08% | The 7-day Larimar Therapeutics Inc. Common Stock model moves from $4.47 to $4.80 (+4.95%). It gives upside momentum context for this stock, so breaks around $4.71 / $4.43 matter more than a single tick. |
The 7-day Larimar Therapeutics Inc. Common Stock model moves from $4.47 to $4.80 (+4.95%). It gives upside momentum context for this stock, so breaks around $4.71 / $4.43 matter more than a single tick. | ||||
| Month | $5.05 ▲ +10.54% | Last Month | $4.37 ▼ -4.43% | The 1-month Larimar Therapeutics Inc. Common Stock target is $5.05 (+10.54%), compared with the live reference near $4.57. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Larimar Therapeutics Inc. Common Stock target is $5.05 (+10.54%), compared with the live reference near $4.57. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $5.43 ▲ +18.93% | Last Year | $4.21 ▼ -7.95% | The 1-year Larimar Therapeutics Inc. Common Stock scenario points to $5.43 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Larimar Therapeutics Inc. Common Stock scenario points to $5.43 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $6.33 ▲ +38.57% | 5 Years Ago | $3.83 ▼ -16.20% | The 5-year Larimar Therapeutics Inc. Common Stock view is $6.33 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Larimar Therapeutics Inc. Common Stock view is $6.33 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $4.57 | Mid |
| Daily Change | -4.99% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $4.57 | Daily Change | -4.99% |
| Market Cap | $474.75M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.